Navigation Links
Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
Date:9/20/2008

early departure from the workforce. Patients treated early with Betaseron fared better in tests of cognitive function compared to those with delayed treatment, which is good news for people with MS," Dr. Freedman said.

The BENEFIT study was the first to demonstrate a reduction in the risk of confirmed EDSS progression, as measured by the Expanded Disability Status Scale (EDSS), with early versus delayed treatment. This effect first appeared at year three, with a significant risk reduction of 40 percent (p=0.022).(2) Over five years, a nominal risk reduction of 24 percent (p=0.177) was observed for early treatment compared to delayed treatment. This difference over five years was not statistically significant.(1)

The key findings from the BENEFIT five-year study showed that:(1)

-- Starting Betaseron after the first clinical event delayed the development of CDMS by more than two years (750 days) in the 40th percentile.

-- Patients treated early with Betaseron had a greater reduction in relapse rate over five years compared to patients with delayed treatment, (0.21 versus 0.27) despite the latter receiving at least three years of treatment after the second attack or after two years (p=0.014; Poisson model). This effect was mainly due to the differences between the groups during the first two years.

-- Early treatment significantly reduced the development of newly active brain lesions (new or enlarging T2 lesions, Gd-enhancing lesions) compared to delayed treatment (p=0.0062).

-- In the BENEFIT study there was a high level of study completion of Betaseron by patients with the earliest signs of MS. Two-thirds of patients (67 percent) in the early treatment group continued on Betaseron for five years.

-- Patients consistently reported a high Health-Related Quality of Life over the five-year study period.

Adverse events (AEs) reported at five years were consistent with the product label.

About BENEFIT

B
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
5. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
6. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
7. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
8. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
9. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
10. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
11. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015 Harwood Feffer LLP ( www.hfesq.com ... directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") ... breached its fiduciary duties to shareholders. On ... announcing results from its first Phase 3 registration trial ... that in the trial, Rhopressa failed to meet its ...
(Date:4/27/2015)... 2015  Eiger BioPharmaceuticals, Incorporated today announced the presentation ... in patients with chronic hepatitis delta viral (HDV) infection. ... at Ankara University Medical School, Turkey ... LOWR HDV - 1 (LOnafarnib With and ... randomized subjects to receive different doses of lonafarnib with ...
(Date:4/27/2015)... N.J. , April 27, 2015  CytoSorbents ... critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine ... announced the appointment of Dr. Joerg Scheier ... Dr. Scheier is a specialist in intensive ... years of combined experience in treating critically-ill patients ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 2CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 3CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 4CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 5
(Date:4/27/2015)... 27, 2015 TayganPoint Consulting Group, ... to announce their sponsorship of Girls on the ... Girls on the Run is a youth development ... grade. The program is delivered through an interactive ... aimed to develop the whole girl – physically, ...
(Date:4/27/2015)... April 27, 2015 Ticket Down is ... at the Alpine Valley Music Theatre and the Isleta ... and Albuquerque, New Mexico area can celebrate because their ... the woods. Buffett will be performing alongside legendary ... His tour stops during the summer and fall months ...
(Date:4/27/2015)... NY (PRWEB) April 27, 2015 The ... creating a seamless referral process for the Health System’s ... chronic heart failure or diabetes, for instance, may have ... primary physicians coordinate with many other care providers. With ... hundreds of thousands of patients each year, the need ...
(Date:4/27/2015)... Scooter Direct is now offering Pride Go Go Traveller ... $929.00, marked down from the MSRP of $1605.00. Scooter ... offering quality mobility solutions to its clients. The online ... chairs, and their accessories at unbeatable prices. ... Traveller Elite, a senior store manager stated, “Electric mobility ...
(Date:4/27/2015)... Consumer Choice Award is thrilled to ... sectors for Ottawa. We would like to extend heartfelt ... superior service has resonated with the people of Ottawa. ... opinions, perceptions and expectations through the responses of thousands ... a rigorous selection process conducted by a third party ...
Breaking Medicine News(10 mins):Health News:TayganPoint Consulting Group Announces Sponsorship of Girls on the Run 2Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2Health News:Mount Sinai Launches System for Faster Referrals 2Health News:Mount Sinai Launches System for Faster Referrals 3Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 3Health News:2015 Ottawa Consumer Choice Award-Winners 2Health News:2015 Ottawa Consumer Choice Award-Winners 3Health News:2015 Ottawa Consumer Choice Award-Winners 4Health News:2015 Ottawa Consumer Choice Award-Winners 5Health News:2015 Ottawa Consumer Choice Award-Winners 6Health News:2015 Ottawa Consumer Choice Award-Winners 7
... , MINNEAPOLIS, Nov. 30 The Eject Helmet Removal ... the Top Fuel, Funny Car, Pro Stock Car and Pro Stock Motorcycle ... Series, as well as for Top Alcohol dragster and Top Alcohol Funny ... is the only product that allows medical caregivers at race tracks ...
... ... discuss living with autism , ... Christi, TX (Vocus) November 30, 2009 -- The 18th annual Texas Autism Conference ... 2009 at the American Bank Center., , , , ,The conference will bring 1,400 attendees and ...
... , , SHORT HILLS, N.J., Nov. 30 ... Inc. and OmniActive Health Technologies, Ltd. ("OmniActive") have reached ... that Kemin,s US Patent No. 5,382,714 ("the ,714 patent") ... from Saponified Marigold Oleoresin and Uses Thereof" and the ...
... , BRIDGEWATER, N.J., Nov. 30 Advanced Health Media, ... programs and commercial compliance management software for the life sciences ... company in the state by NJBIZ, New Jersey,s leading statewide ... top fifty businesses that have made significant contributions to the ...
... joy and comfort that an animal can provide, especially ... of the family and irreplaceable companions. A growing body ... bond in child development, elderly care, mental illness, physical ... of incarcerated youth and adults. In two articles ...
... drink heavily more often than younger people, study finds, , ... problem drinkers consume more alcohol than their younger counterparts, a ... achieve the same effect. , According to a study ... than 60 consume more than 40 drinks a week, on ...
Cached Medicine News:Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Advanced Health Media Honored at NJ Finest Award Ceremony 2Health News:The therapeutic benefits of the human-animal bond 2Health News:Binge Drinking Not Just a Rite of the Young 2
... System is the smallest and lightest continuous ... market. It is designed to help active ... complying with therapy. The GoodKnight 420S model ... usage data. It also detects persistent residual ...
Chase micro-hemocrit tubes are manufactured from soda lime glass, packed in plastic vials with reclosable snap-lock caps to maintain cleanliness....
Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
... help protect healthcare workers from accidental injury ... procedures. Each BD plastic-coated micro-hematocrit is encased ... that it does not interfere with the ... the sample. The mylar film will keep ...
Medicine Products: